Testing effectiveness (Phase 2)Study completedNCT01034878What this trial is testingSunitinib in Metastatic Renal CancerWho this might be right forCarcinoma, Renal Cell Istituto Clinico Humanitas 25
Testing effectiveness (Phase 2)Looking for participantsNCT05127824What this trial is testingAutologous Dendritic Cell Vaccine in Kidney CancerWho this might be right forCarcinoma, Renal Cell Jodi Maranchie 42
Not applicableNo Longer AvailableNCT05941637What this trial is testingAn Expanded Access Program to Axitinib is Available for Patients With Advanced Forms of Kidney Cancer (Ductal; Papillary; Chromophobic; Oncocytic) With Mutations in VHL, PBRM1 / BAP1, SETD2, VEGF)Who this might be right forClear Cell Kidney CancerKidney CancerKidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Lynkcell Europe
Testing effectiveness (Phase 2)Study completedNCT00425386What this trial is testingSunitinib and Erlotinib in Treating Patients With Unresectable or Metastatic Kidney CancerWho this might be right forKidney Cancer OHSU Knight Cancer Institute 60
Testing effectiveness (Phase 2)UnknownNCT01219751What this trial is testingTrial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell CarcinomaWho this might be right forMetastatic Renal Cell Carcinoma Asan Medical Center 35
Testing effectiveness (Phase 2)Study completedNCT03108066What this trial is testingMK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)Who this might be right forVHL Gene MutationVHLVHL Syndrome+8 more Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 4
Testing effectiveness (Phase 2)Study completedNCT00550277What this trial is testingLBH589 Treatment for Refractory Clear Cell Renal CarcinomaWho this might be right forRenal Cell Carcinoma SCRI Development Innovations, LLC 20
Early research (Phase 1)Active Not RecruitingNCT04483778What this trial is testingB7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsWho this might be right forPediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more Seattle Children's Hospital 68
Testing effectiveness (Phase 2)Study completedNCT00278174What this trial is testingInterferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney CancerWho this might be right forKidney Cancer Case Comprehensive Cancer Center 7
Not applicableWithdrawnNCT00908739What this trial is testingStudying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney CancerWho this might be right forKidney Cancer Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06361810What this trial is testingPSMA Therapy and Immunotherapy in Kidney CancerWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Clear Cell Renal Cell Carcinoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Ended earlyNCT04438083What this trial is testingA Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)Who this might be right forRenal Cell Carcinoma CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT00142415What this trial is testingPhase I/II Dose-escalation Study of Lutetium-177-labeled cG250 in Patients With Advanced Renal CancerWho this might be right forMetastatic Renal Cell Carcinoma Ludwig Institute for Cancer Research 26
Not applicableStudy completedNCT00900536What this trial is testingDNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCEWho this might be right forKidney Cancer Medical Research Council
Early research (Phase 1)Study completedNCT04627064What this trial is testingABEMA Alone or in COMBO With MK-6482Who this might be right forClear Cell Renal Cell Carcinoma Dana-Farber Cancer Institute 11
Early research (Phase 1)Not Yet RecruitingNCT05698238What this trial is testingClinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell Carcinoma MetastaticTNBC - Triple-Negative Breast CancerHead and Neck Cancer+2 more Mabpro, a.s. 50
Testing effectiveness (Phase 2)Ended earlyNCT02089334What this trial is testingDose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell CancerWho this might be right forMetastatic Renal Cell Cancer Rexahn Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT00244764What this trial is testingGW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forCarcinoma, Renal Cell GlaxoSmithKline 225
Early research (Phase 1)Study completedNCT05585034What this trial is testingPhase 1, First-in-human, Dose-finding and Expansion Study to Evaluate XmAb®808 in Combination With Pembrolizumab in Advanced Solid TumorsWho this might be right forHead and Neck Squamous Cell CarcinomaMelanoma Excluding Uveal MelanomaNon-small Cell Lung Cancer, Squamous or Non-squamous+6 more Xencor, Inc. 60
Testing effectiveness (Phase 2)Ended earlyNCT03334409What this trial is testingPazopanib Hydrochloride With or Without Ascorbic Acid in Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed by SurgeryWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+2 more Academic and Community Cancer Research United 5